跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,171 条关于
“Samchundang Pharm”
全部
3,171
临床试验
417
药物
635
机构
994
资讯
1,125
上个月
Samchundang Pharm Reaches Global Settlement in Eylea Biosimilar Patent Dispute, Clearing Path for SCD411 Commercialization
5个月前
Samchundang Pharmaceutical Completes Global Patent Restructuring for S-PASS Oral Drug Delivery Platform
6个月前
Samchundang Secures $4 Billion European GLP-1 Deal with Breakthrough Patent-Circumventing Technology
5个月前
ST Pharm Secures First Japanese Patent for mRNA-LNP Platform Technology STP1244
去年
Hanmi Pharm Seeks Approval for Triple-Combination Hypertension Drug Amosartan PLUS-L
去年
Hanmi Pharm Accelerates Launch of Efpeglenatide for Obesity Treatment
9个月前
R-Pharm Advances Three Cancer Drugs Through Clinical Development, Including Novel Antiandrogen for Prostate Cancer
12个月前
R-Pharm Presents Long-Term Olokizumab Data Showing Sustained Improvement in Rheumatoid Arthritis Patients
去年
R-Pharm's Pembrolizumab Biosimilar, Arfleyda, Shows Non-Inferiority in Phase III Melanoma Trial
8个月前
Adlai Nortye Partners with ASK Pharm in $230 Million Deal for Pan-RAS Inhibitor AN9025 in Greater China
第 1 页,共 113 页
上一页
下一页